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An Artificial Transplantation Site for Pancreatic Islets
P. De Vos, J.L. Hillebrands, B.J. De Haan, J.H. Strubbe, and R. Van Schilfgaarde
MICROENCAPSULATED islets still have their func-tional limitations.1 Transplantation near blood
vessels may improve the function.2 An intraperitoneally
located and prevascularized expanded polytetrafluouroeth-
ylene (ePTFE) solid support is potentially a suitable trans-
plantation site for encapsulated pancreatic islets because it
allows both for the implantation of a large volume islet graft
in the immediate vicinity of blood vessels and for its
complete removal. ePTFE seems a suitable material for the
construction of solid supports as it is biocompatible3 and
can be coated to induce vascularization.4 The present study
investigates the efficacy of an ePTFE solid support for the
implantation of nonencapsulated islet isografts in strepto-
zotocin-induced diabetic rat recipients.
MATERIALS AND METHOD
Solid supports were prepared from expanded fibers of ePTFE
(courtesy of W.L. Gore & Associates). Islet isografts were trans-
planted in streptozotocin-induced diabetic rat recipients 4 weeks
after intraperitoneal implantation of the supports. Diabetic rats
transplanted with islets in the unmodified peritoneal cavity served
as controls. Recipients of successful grafts were provided with
permanent cardiac catheters for blood sampling and infusion in
undisturbed, freely moving rats.
RESULTS AND DISCUSSION
Solid supports were always coated with a-FGF because we
found that this growth factor enchances the neovasculariza-
tion. The success rates of 5-mL (group A) and 10-mL (group
B) islet isografts in solid supports were compared to the
success rates of 5-mL (group C) and 10-mL (group D) islet
isografts implanted in the unmodified peritoneal cavity.
Four of seven rats in group A and all seven rats in group B
became normoglycemic for at least 6 months. Only two of
eight rats in group C and 4 of 11 rats in group D showed
normoglycemia, which lasted for at least 6 months in none
of two in group C and three of four in group D. Because of
the low success rates in groups C and D, intravenous and
oral glucose testing were restricted to the successful recip-
ients in groups A and B. Glucose tolerance was found to be
proportional to the grafted islet volume but, expectedly,5 in
both groups the glucose tolerance and the insulin responses
were somewhat lower than in controls. Thus, the present
results show that the prevascularized ePTFE solid support
rather than the unmodified peritoneal cavity is an effica-
cious transplantation site.
The principle of grafting in solid support is also applica-
ble for encapsulated islets which, as a consequence of its
large volume, can only be transplanted in the peritoneal
cavity as a nonvascularized, freely floating graft. However,
the ePTFE solid support as used for nonencapsulated islets
in the present study has to be modified to serve as a
transplantation site for encapsulated islets because grafting
between the ePTFE fibers was found to be associated with
damage to the encapsulated islets via the following two
mechanisms. Grafting in ePTFE solid supports requires
preparation of multiple tunnels by puncturing.6 This punc-
turing is followed by a wound healing process which is
associated with cytokine release and damage to the encap-
sulated islets. Second, and most importantly, we found that
grafting of the capsules into the present support was
associated with induction of imperfections onto the capsule
surface which resulted in fibrotic overgrowth of the im-
planted capsules with ischemia, and necrosis of the encap-
sulated islets as a consequence. Probably, the closure of the
punctions is associated with mechanical pressure on the
capsules which induces breakage of the capsule membrane.
Our research now concentrates on creating a vascularized
ePTFE support with an accessible hollow, chamber-like
space that can serve as a transplantation site for encapsu-
lated islets.
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